Result of General Meeting and Total Voting Rights
Futura Medical PLC announced that all resolutions presented at its General Meeting were passed with overwhelming support, with over 99.23% of votes cast in favour of each resolution, paving the way for the completion of its placing and subscription fundraise. Following the admission of 13,200,000 Subscription Shares and 231,800,000 Conditional Placing Shares to AIM, expected around December 4, 2025, the company's total issued ordinary shares will be 581,120,659. This significant capital raise and share issuance will impact the company's total voting rights and may be used by shareholders for disclosure notification calculations.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical (AIM:FUM), the consumer healthcare Group behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, announces that following the General Meeting held earlier today at the Company's registered offices at 10 a.m., all resolutions set out in the notice of General Meeting contained in the Circulated dated 13 November 2025 were duly passed.
Resolutions 1 and 3 were proposed as ordinary resolutions and resolutions 2, 4 and 5 were proposed as special resolutions. The total number of votes received on each resolution were as follows:
| For | Against | |||||
|---|---|---|---|---|---|---|
| Resolution | Votes For | % of votes cast | Votes Against | % of votes cast | Votes withheld | Total votes cast |
| 1 | 154,316,685 | 99.23 | 1,203,457 | 0.77 | 198,143 | 155,718,285 |
| 2 | 154,329,985 | 99.23 | 1,200,657 | 0.77 | 187,643 | 155,718,285 |
| 3 | 154,316,685 | 99.23 | 1,203,457 | 0.77 | 198,143 | 155,718,285 |
| 4 | 154,316,485 | 99.23 | 1,203,657 | 0.77 | 198,143 | 155,718,285 |
| 5 | 154,314,875 | 99.23 | 1,205,267 | 0.77 | 198,143 | 155,718,285 |
Accordingly, all conditions precedent relating to the proposed placing and subscription (the "Fundraise") announced on 13 November 2025 have now been met (save for Subsequent Admission).
Application has been made for 13,200,000 Subscription Shares and 231,800,000 Conditional Placing Shares to be admitted to trading on AIM, it is expected that the admission will become effective and that dealings will commence at 8.00 a.m. on or around 4 December 2025.
Total Voting Rights
Following the Admission, the Company will have 581,120,659 ordinary shares of £0.002 each in issue.
The Company does not hold any shares in treasury and all of the Ordinary Shares have equal voting rights. Therefore, the figures above represent the total voting rights in the Company and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules
Unless otherwise stated, capitalised terms not otherwise defined in the text of this announcement have the same meanings ascribed to them as in the announcement released by the Company on 13 November 2025.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.